Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Under the terms of the agreement, Pfizer has the right to extend the term for up to an additional two years. Financial details of the agreement were not disclosed.
read more
Wednesday, April 02, 2014
ICON plc, (NASDAQ: ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has agreed, subject to certain closing conditions, to acquire Aptiv Solutions ...
read more
ICON plc, a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, has agreed, subject to certain customary closing conditions (including applicable regulatory approvals), to ...
read more
Tuesday, February 05, 2013
ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has agreed, subject to certain closing conditions, to acquire the Clinical Trial Services ...
read more
ICON plc, (NASDAQ: ICLR) a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that its Firecrest training meets TransCelerate BioPharma Inc.’s minimum criteria for ...
read more
Icosagen, a CRDMO with expertise in innovative antibody research and production, announced a strategic partnership on selected projects with Lead Discovery Center GmbH (LDC), a translational drug discovery organization tapping on a broad network in ...
read more
Wednesday, August 29, 2018
ICS announced the grand opening of its newest third-party logistics (3PL) pharmaceutical distribution center in Ohio.
read more
IDBS, a leading innovator in Biopharmaceutical Lifecycle Management (BPLM), and Scitara, a pioneer in laboratory IoT, have entered into a strategic partnership to create a combined solution that will significantly extend IDBS Polar BPLM’s laboratory ...
read more
Wednesday, April 01, 2020
Anaqua’s ideaPoint announced a strategic partnership with clinical data company WideTrial to facilitate greater access to investigational medicines for physicians and patients dealing with COVID-19 worldwide.
read more
Wednesday, March 18, 2020
IDEAYA has entered into a clinical trial collaboration and supply agreement with Pfizer for an IDEAYA-sponsored clinical combination study of IDE196 in the U.S. and Canada.
read more
Wednesday, March 28, 2018
Idifarma has announced new GMP spray drying capabilities for highly potent drugs up to Category 4 OEL/OEB.
read more
Thursday, December 03, 2020
Idifarma has announced a partnership with Stefano Console from Swiss life sciences consultancy Oriento.
read more
A CDMO has expanded its GMP manufacturing offering with the installation of new automatic capsule filling capabilities at its EU-GMP approved plant in Spain.
read more
Idifarma has begun its seventh project with Spanish biotechnology company, Palobiofarma.
read more
Wednesday, December 07, 2016
Idifarma has acquired a Bosch GKF-702 capsule filling machine, capable of manufacturing from 3,000 to 42,000 capsules per hour. The new equipment will be installed at the CDMO’s EU-GMP approved plant in Pamplona, Spain, in early 2017.
read more